Alonso VMO, Chagury AA, Hachiya A, Imamura R, Tsuji DH, Sennes LU. Diffusion of aniline blue injected into the thyroarytenoid muscle as a proxy for botulinum toxin injection: an experimental study in cadaver larynges. Int Arch Otorhinolaryngol. 2013;17(3):315–320.

Barkmeier JM, Case JL, Ludlow CL. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges. J Commun Disord. 2001;34(1-2):21-37.

Behlau M. Voz: Disfonias Neurológicas. In: O Livro do Especialista, o volume II. Rio de Janeiro: Revinter; 2005. Pag 146-47.

Edgar JD, Sapienza CM, Bidus K, Ludlow CL. Acoustic measures of symptoms in abductor spasmodic dysphonia. J Voice. 2001 Sep;15(3):362-72.

Gielow I. Distonia focal laríngea de adução tratada por injeções bilaterais de toxina botulínica: estudo retrospectivo da relação entre dose, tempo de benefício e efeitos adversos. Tese de doutorado. UNIFESP, São Paulo, 2002.

Grillone GA, Chan T. Laryngeal dystonia. Otolaryngol Clin North Am. 2006;39(1):87-100.

Isshiki N, Tsuji DH, Yamamoto Y, Iizuka Y. Midline lateralization thyroplasty for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol.2000;109(2):187-93

Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008;139(4):495-505.

Ludlow CL. Treatment for spasmodic dysphonia: limitations of current approaches. Curr Opin Otolaryngol Head Neck Surg. 2009;17(3):160-5.

Ludlow CL. Spasmodic dysphonia: a laryngeal control disorder specific to speech. J Neurosci. 2011;31(3):793-7.

Murry T. Spasmodic dysphonia: let's look at that again. J Voice. 2014;28(6):694-9.

Roy N. Differential diagnosis of muscle tension dysphonia and spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg. 2010;18(3):165-70.

Simonyan K, Ludlow CL. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex. 2010;20(11):2749-59.

Simonyan K, Ludlow CL. Abnormal structure-function relationship in spasmodic dysphonia. Cereb Cortex. 2012;22(2):417-25.

Tsuji DH, Pinho SMR, Barbosa ER, Miniti A. Botulinum Toxin Injection Without Eletromyography Control for the Treatment of Spastic Dysphonia - a Prefminary Report. Braz J Otorhinolaryngol. 1994;60:145-48.

Tsuji DH, Isshiki N, Sennes LU, Sperandio FA, Santos Júnior RC, Pinho SMR. Disfonia Espasmódica em adução: Proposta de um tratamento definitivo. Arq Fund Otorrinolaringol.2000;4(1):24-27.

Tsuji DH, Sennes LU, Imamura R, Koishi HU. Técnica de Injeção da Toxina Botulínica Através do Nasofibroscópio. Arq Fund Otorrinolaringol.2001;5(3):137-143.

Tsuji DH, Sennes LU, Imamura R, Pinho SMR, Braga NMA. Miectomia parcial do músculo tireoaritenóideo como tratamento para disfonia espasmódica de adução. Arq Fund Otorrinolaringol.2002;6(1):89-95.

Tsuji DH. Neurectomia do ramo tireoaritenóideo do nervo laríngeo inferior, via endoscópica, associada à miectomia parcial do músculo tireoaritenóideo com laser de CO2. Tese (Livre Docência). Faculdade de Medicina da Universidade de São Paulo, Brasil, v. 01, 2002.

Tsuji DH, Chrispim FS, Imamura R, Sennes LU, Hachiya A. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia. Braz J Otorhinolaryngol. 2006;72(2):261-6.

Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality. J Voice. 2012;26(5):666.e7-12.